Structural placental tissue comprised of human umbilical cord, preserved to retain native tissue components to help manage challenging wounds and compromised surgical sites to help patients get back to their lives1,2
STRAVIX PL◊ Lyopreserved Umbilical Tissue and STRAVIX Cryopreserved Umbilical Tissue are highly versatile, with both wound and surgical applications:
Manufactured using proprietary lyopreservation or cryopreservation processes, blood vessels are removed to prevent an immune response while retaining growth factors and an extracellular matrix rich in hyaluronic acid.1,2
STRAVIX Tissues offer advanced modalities that can be used to cover hard-to-heal wounds, including:
Please see each products’ Instructions for Use for important safety information including approved uses.
STRAVIX PL & STRAVIX Customer Care:
◊Osiris, STRAVIX PL and STRAVIX Tissue are trademarks of Osiris Therapeutics, Inc., a wholly owned direct subsidiary of Smith+Nephew Consolidated, Inc.
All Trademarks acknowledged.
Recall and Complaints
Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to complaints@smith-nephew.com.
Terms & Conditions and Warranties
1. Dhall S, et al. Bioact Mater. 2018; 4(1): 97-106.
2. Data on file at Osiris Therapeutics, Inc
3. Woo KY. Woundsource (White Paper) 2014.